Angiogenesis inhibitor therapies for advanced renal cell carcinoma: Toxicity and treatment patterns in clinical practice from a global medical chart review

Angiogenesis inhibitor therapies for advanced renal cell carcinoma: Toxicity and treatment patterns in clinical practice from a global medical chart review

The aim of this study was to assess the treatment patterns and safety of sunitinib, sorafenib and bevacizumab in real-world clinical settings in US, Europe and Asia. Medical records were abstracted at 18 community oncology clinics in the US and at 21 tertiary oncology centers in US, Europe and Asia...

Full description

Bibliographic Details
Main Authors: OH, WILLIAM K., McDERMOTT, DAVID, PORTA, CAMILLO, LEVY, ANTONIN, ELAIDI, REZA, SCOTTE, FLORIAN, HAWKINS, ROBERT, CASTELLANO, DANIEL, BELLMUNT, JOAQUIM, RHA, SUN YOUNG, SUN, JONG-MU, NATHAN, PAUL, FEINBERG, BRUCE A., SCOTT, JEFFREY, McDERMOTT, RAY, AHN, JIN-HEE, WAGSTAFF, JOHN, CHANG, YEN-HWA, OU, YEN-CHUAN, DONNELLAN, PAUL, HUANG, CHAO-YUAN, McCAFFREY, JOHN, CHIANG, PO-HUI, CHUANG, CHENG-KENG, KORVES, CAROLINE, NEARY, MAUREEN P., DIAZ, JOSE R., MEHMUD, FAISAL, DUH, MEI SHENG
Format: Online
Language:English
Published: D.A. Spandidos 2013
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3867384/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3867384/

Similar Items